- Maybe Money Can Help Buy Happiness, After All
- Will Vaccines Work Against the New Coronavirus Variants?
- AHA News: Keeping Your Brain Sharp Isn’t About Working More Puzzles
- Could Stem Cell Therapy Be a Breakthrough Against MS?
- Diabetes Boosts Odds for Heart Trouble 10-fold in Younger Women
- Severe Allergic Reaction Extremely Rare With Pfizer COVID Vaccine: Study
- Biden Unveils Details of National Pandemic Response Plan
- Health Highlights: Jan. 21, 2021
- Biden COVID Advisor Says Poor Preparation, Changing Virus Could Slow Vaccine Effort
- Arthritis Drug Tocilizumab Flops as COVID-19 Treatment
Gene Study Helps Advance Diagnosis of Cystic Fibrosis

MONDAY, Aug. 26Researchers who identified 105 new genetic mutations that cause cystic fibrosis say their findings will improve diagnosis and could increase the number of patients who receive individualized drug treatment.
Cystic fibrosis is a genetic disorder that causes a buildup of thick mucus in the lungs, resulting in frequent lung infections, breathing problems and decreased lung function. Eventually, the repeated infections destroy the lungs.
More than 1,900 mutations had already been identified in the gene responsible for cystic fibrosis, but it was unclear how many of them actually contribute to the disease.
In this study, researchers analyzed genetic information from nearly 40,000 cystic fibrosis patients in order to determine which of the 1,900 mutations are benign and which are harmful. Their findings increased the number of mutations known to cause cystic fibrosis from 22 to 127.
The study was published online Aug. 25 in the journal Nature Genetics.
Identification of these additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene will bring certainty to families about whether someone has cystic fibrosis or is a carrier, and will also help efforts to design new drugs that target specific mutations. There is already one such drug on the market.
“Since not all mutations cause disease, sequencing the DNA in both copies of your CFTR gene and finding an abnormality in one wouldn’t tell us if you are a carrier for [cystic fibrosis] unless we knew if that abnormality causes [cystic fibrosis],” Dr. Garry Cutting, a professor of pediatrics in the McKusick-Nathans Institute of Genetic Medicine at the Johns Hopkins University School of Medicine, said in a Hopkins news release.
“Until this new work, more than a quarter of couples in which both partners were found to carry a CFTR mutation were left wondering if their mutations were going to affect their offspring. Now it’s down to 9 percent,” he explained.
More information
The U.S. National Heart, Lung, and Blood Institute has more about cystic fibrosis.
Source: HealthDay